• Contact Us
  • Environment
  • News
  • Careers
Kent Pharmaceutical Logo
  • Home
  • About Us
  • Our Products
  • Manufacturing
  • Sales
  • NHS
Amgen's BiTE® antibody blinatumomab (AMG 103) achieved high rate of complete response  |  Merck total revenues increase 3.2% to € 2.6 billion  |  Pfizer provides topline results from Phase 3 study of Torisel®  |  In drug-approval race, US FDA ahead of Canada, Europe  |  GlaxoSmithKline to fully acquire Cellzome for £61 million  |  Bristol-Myers Squibb Foundation Announces $15 Million Expansion of Together on Diabetes® to China and India  |  Bristol-Myers Squibb and Tsinghua University Enter Strategic Partnership  |  Blood pressure drugs don't protect against colorectal cancer  |  Statistically significant clinical phase III results of Lu AA21004  |  Vitamin K2: New hope for Parkinson's patients?  |   rss

Dressings and surgicals

  • Products
  • Kent Label
  • Generics
  • P.I.s
  • UK Packs
  • OTC
  • Dressings and Surgicals
  • Anaesthetics
  • Special Services
  • Early Bird
  • Safe-Inject

 

Dressings and Surgicals

  • a
  • b
  • c
  • d
  • e
  • f
  • g
  • h
  • i
  • j
  • k
  • l
  • m
  • n
  • o
  • p
  • q
  • r
  • s
  • t
  • u
  • v
  • w
  • x
  • y
  • z

Please select a letter above.

  • Kent Connect
  • Manufacturing
  • NHS
  • Repackaging
  • Products
  • Retail
  • Wholesale
  • About Us
  • Careers
  • Community
  • Contact Us
  • Environment
  • Security & Privacy
  • Terms & Conditions

Contact Us
T.0845 437 5565
F.0845 437 5567
info@kentpharm.co.uk
© 2012 Kent Pharmaceuticals Ltd.

Website Design and Development
WillCreate
Sitemap